Home/Filings/4/0001140361-08-001862
4//SEC Filing

SCICLONE PHARMACEUTICALS INC 4

Accession 0001140361-08-001862

CIK 0000880771operating

Filed

Jan 23, 7:00 PM ET

Accepted

Jan 24, 2:18 PM ET

Size

19.1 KB

Accession

0001140361-08-001862

Insider Transaction Report

Form 4
Period: 2008-01-22
Transactions
  • Purchase

    Common Stock

    2008-01-23$2.01/sh+22,098$44,4816,515,651 total(indirect: I)
  • Purchase

    Common Stock

    2008-01-22$2.01/sh+7,035$14,1496,493,553 total(indirect: I)
Transactions
  • Purchase

    Common Stock

    2008-01-23$2.01/sh+22,098$44,4816,515,651 total(indirect: I)
  • Purchase

    Common Stock

    2008-01-22$2.01/sh+7,035$14,1496,493,553 total(indirect: I)
Footnotes (1)
  • [F1]Shares directly owned by Defiante Farmaceutica, L.D.A. (?Defiante?). Defiante is 58% directly owned by Sigma Tau Finanzaria S.p.A. ("Sigma Tau") and 42% directly owned by Sigma Tau's wholly-owned subsidi-ary, Sigma Tau International S.A.

Issuer

SCICLONE PHARMACEUTICALS INC

CIK 0000880771

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000880771

Filing Metadata

Form type
4
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 2:18 PM ET
Size
19.1 KB